West Pharmaceutical Services Inc. buy BNP Paribas Exane
Start price
13.07.26
/
50%
€313.50
Target price
13.07.27
€392.24
Performance (%)
-3.51%
Price
04.08.26
€302.50
Summary
This prediction is currently active. With a performance of -3.51%, the BUY prediction for West Pharmaceutical Services Inc. by BNP_Paribas_Exane is down slightly. This prediction currently runs until 13.07.27. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| West Pharmaceutical Services Inc. | 3.880% |
| iShares Core DAX® | 3,15 % |
| iShares Nasdaq 100 | 7,43 % |
| iShares Nikkei 225® | 8,57 % |
| iShares S&P 500 | 4,58 % |
Comments by BNP_Paribas_Exane for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services (WST) is now covered by BNP Paribas Exane. They set an "outperform" rating and a $447.00 price target on the stock.
Ratings data for WST provided by MarketBeat